Osteoporosis | The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

Osteoporosis research study

What is the primary objective of this study?

To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture

Who is eligible to participate?

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?


Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.


Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status

Unknown status

Start Date: January 2003

Completed Date: April 2007

Phase: Phase 3

Type: Interventional


Primary Outcome:

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Richard Kremer, MD PhD

Lead Sponsor: McGill University Health Center

Collaborator: Merck Frosst Canada Ltd.

More information:

Discuss Fosamax